June 07, 2018
Rose
Stakeholders across healthcare are beginning to weigh the benefits and challenges digital therapeutics could bring to their businesses, and pharma is no exception. During an afternoon roundtable session held yesterday at BIO 2018 in Boston, a panel of digital medicine and pharmaceutical representatives discussed the impact that these novel medicines has had, and could have, on drugmakers, regulators, and those prescribing the medications.
from MobiHealthNews https://ift.tt/2HrewL3
June 07, 2018
Rose
MobiHealthNews
No comments
Related Posts:
Medtronic's deep brain stimulation programmer and app get the FDA nod- 6 former Fitbit, Jawbone employees indicted by federal grand jury
- How Sitra is fostering healthcare innovation in Finland
- Digital mental health platform Healios raises $2.9M
- Health 2.0 and HIMSS: Why coming together strengthens the healthcare community
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment